Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Monitor Closely (3)darifenacin decreases levels of ziprasidone by inhibition of GI absorption. pancuronium decreases levels of ziprasidone by inhibition of GI absorption. Minor (1)ritonavir will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Additive anticholinergic effects, possible hypoglycemia. Monitor Closely (1)ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. disopyramide and ziprasidone both increase QTc interval. Serious - Use Alternative (1)artemether/lumefantrine and ziprasidone both increase QTc interval. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Serious - Use Alternative (1)mobocertinib and ziprasidone both increase QTc interval. Minor/Significance Unknown. Effect of interaction is not clear, use caution. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Minor (1)rufinamide will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)ziprasidone and lenvatinib both increase QTc interval. In order to ensure use of the lowest effective dose, patients should ordinarily be observed for improvement for several weeks before upward dosage adjustment. Adjust finererone dosage as needed. ziprasidone and imipramine both increase sedation. Applies only to oral form of both agents. QT interval should be monitored when ezogabine is prescribed with agents known to increase QT interval. Use Caution/Monitor.ziprasidone increases effects of diphenhydramine by pharmacodynamic synergism. Monitor Closely (1)osilodrostat and ziprasidone both increase QTc interval. Use Caution/Monitor. Use Caution/Monitor. hydroxyzine and ziprasidone both increase sedation. Contraindicated. Avoid or Use Alternate Drug. carbamazepine will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Additive anticholinergic effects, possible hypoglycemia. sorafenib and ziprasidone both increase QTc interval. cyclizine decreases levels of ziprasidone by pharmacodynamic antagonism. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Use Caution/Monitor. NOTES: Do not share this medication with others.Lab and/or medical tests (such as blood mineral levels, blood sugar, EKG) should be done while you are taking this medication. Monitor Closely (1)cinnarizine and ziprasidone both increase sedation. ziprasidone and tetrabenazine both increase antidopaminergic effects, including extrapyramidal symptoms and neuroleptic malignant syndrome. siponimod and ziprasidone both increase QTc interval. Use Caution/Monitor. Avoid or Use Alternate Drug. Monitor Closely (3)rapacuronium decreases levels of ziprasidone by inhibition of GI absorption. Monitor Closely (1)lormetazepam and ziprasidone both increase sedation. An increase to a dose greater than 80 mg twice daily is not generally recommended. nalbuphine and ziprasidone both increase sedation. pentazocine and ziprasidone both increase sedation. If you already have diabetes, check your blood sugar regularly as directed and share the results with your doctor. Use Caution/Monitor.oxybutynin topical decreases levels of ziprasidone by pharmacodynamic antagonism. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). Use Caution/Monitor. Contraindicated. ziprasidone decreases effects of insulin inhaled by Other (see comment). Monitor Closely (1)lorcaserin, ziprasidone. Use Caution/Monitor. unspecified interaction mechanism. Contraindicated. Either increases effects of the other by QTc interval. Use Caution/Monitor. methocarbamol and ziprasidone both increase sedation. Use Caution/Monitor. artemether/lumefantrine and ziprasidone both increase QTc interval. QTc prolongation reported with higher than recommended doses of fostemsavir. fosphenytoin will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Unsteadiness and drowsiness may increase the risk of falls. Use Caution/Monitor. Monitor Closely (1)ziprasidone and maprotiline both increase sedation. dicyclomine decreases levels of ziprasidone by inhibition of GI absorption. ziprasidone increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)ziprasidone, glimepiride. Avoid coadministration of fexinidazole with drugs known to block potassium channels and/or prolong QT interval. glycopyrrolate inhaled decreases levels of ziprasidone by pharmacodynamic antagonism. Contraindicated. Use Caution/Monitor. Use Caution/Monitor. prochlorperazine and ziprasidone both increase sedation. Either increases effects of the other by anti-hypertensive channel blocking. Use Caution/Monitor. vecuronium decreases levels of ziprasidone by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Monitor Closely (1)fluoxetine and ziprasidone both increase QTc interval. unspecified interaction mechanism. Get medical help right away if you have any of the following symptoms: fever, muscle stiffness/pain/tenderness/weakness, severe tiredness, severe confusion, sweating, fast/irregular heartbeat, dark urine, signs of kidney problems (such as change in the amount of urine).Rarely, males may have a painful or prolonged erection lasting 4 or more hours. Limit dosages and durations to the minimum required. artemether/lumefantrine will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Consider predose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias. Applies only to oral form of both agents. Take your next dose at the regular time. Other (see comment). Contact the applicable plan Monitor Closely (1)ziprasidone and topiramate both increase sedation. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)lofepramine and ziprasidone both increase QTc interval. Use Caution/Monitor. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. unspecified interaction mechanism. Avoid coadministration with drugs that prolong QT interval, which could increase risk for developing torsade de pointes-type ventricular tachycardia. Avoid or Use Alternate Drug. Either increases toxicity of the other by sedation. fludrocortisone will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)grapefruit will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. lasmiditan, ziprasidone. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Monitor Closely (1)trimethoprim and ziprasidone both increase QTc interval. Use Caution/Monitor. Use Caution/Monitor. ziprasidone and nortriptyline both increase sedation. Monitor Closely (1)ziprasidone, glyburide. Use Caution/Monitor.Serious - Use Alternative (1)mirtazapine and ziprasidone both increase QTc interval. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor.pimozide and ziprasidone both increase sedation. azelastine and ziprasidone both increase sedation. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. erythromycin ethylsuccinate will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Always ask your health care professional for complete information about this product and your specific health needs. solifenacin decreases levels of ziprasidone by inhibition of GI absorption. Talk to your doctor about using ziprasidone safely.This drug may make you dizzy or drowsy. Monitor Closely (1)ketoconazole will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Contraindicated. Use Caution/Monitor. Monitor Closely (1)tapentadol and ziprasidone both increase sedation. Use Caution/Monitor. Minor/Significance Unknown. Other (see comment). Contraindicated.Serious - Use Alternative (1)citalopram and ziprasidone both increase QTc interval. Contraindicated. Comment: Avoid use of metoclopramide intranasal or interacting drug, depending on importance of drug to patient.ziprasidone increases toxicity of metoclopramide intranasal by pharmacodynamic synergism. Use Caution/Monitor.cyclizine decreases levels of ziprasidone by inhibition of GI absorption. Use Caution/Monitor. Use Caution/Monitor. Avoid or Use Alternate Drug. Monitor Closely (1)acrivastine and ziprasidone both increase sedation. ziprasidone decreases effects of safinamide by pharmacodynamic antagonism. Either increases toxicity of the other by pharmacodynamic synergism. Monitor Closely (3)promethazine, ziprasidone. Monitor Closely (1)nalbuphine and ziprasidone both increase sedation. Use Caution/Monitor. ziprasidone, metformin. ziprasidone increases effects of dicyclomine by pharmacodynamic synergism. ziprasidone and entrectinib both increase QTc interval. ziprasidone and nabilone both increase sedation. unspecified interaction mechanism. Use Caution/Monitor.ziprasidone increases effects of cyclizine by pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)dextromethorphan, ziprasidone. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Avoid or Use Alternate Drug. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)ketoconazole and ziprasidone both increase QTc interval. Other (see comment). Use Caution/Monitor. Use Caution/Monitor.albuterol and ziprasidone both increase QTc interval. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Modify Therapy/Monitor Closely. Color: colorless Shape: Imprint: This medicine is a colorless, vial . Comment: Increases risk of neuroleptic malignant syndromeIncreases risk of neuroleptic malignant syndrome. A: Generally acceptable. Monitor Closely (1)telavancin and ziprasidone both increase QTc interval. Serious - Use Alternative (1)ziprasidone and entrectinib both increase QTc interval. Minor/Significance Unknown. MISSED DOSE: If you miss a dose, take it as soon as you remember. Use Caution/Monitor.paliperidone and ziprasidone both increase QTc interval. Avoid or Use Alternate Drug. Use Caution/Monitor.Serious - Use Alternative (1)nortriptyline and ziprasidone both increase QTc interval. Patients treated with selinexor may experience neurological toxicities. Other (see comment). Modify Therapy/Monitor Closely. Other (see comment). Serious - Use Alternative (1)ziprasidone and panobinostat both increase QTc interval. Monitor closely for signs of respiratory depression and sedation. Minor/Significance Unknown. Administration Information for GEODON Capsules Administer GEODON capsules orally with food. Serious - Use Alternative (1)ribociclib and ziprasidone both increase QTc interval. Effect of interaction is not clear, use caution. ziprasidone and ondansetron both increase QTc interval. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. amobarbital and ziprasidone both increase sedation. anticholinergic/sedative combos decreases levels of ziprasidone by inhibition of GI absorption. Modify Therapy/Monitor Closely. Applies only to oral form of both agents. Effect of interaction is not clear, use caution. Monitor Closely (1)asenapine transdermal and ziprasidone both increase sedation. Use Caution/Monitor. Administer GEODON capsules orally with food. ziprasidone and melatonin both increase sedation. Use Caution/Monitor. Neither high-dose nor low-dose ziprasidone provided any benefit. aprepitant will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)ziprasidone increases and metaproterenol decreases sedation. Applies only to oral form of both agents. In some patients, daily dosage may subsequently be adjusted on the basis of individual clinical status up to 80 mg twice daily. Initiate with lower doses and monitor for signs and symptoms of serotonin syndrome, particularly during initiation or dosage increase. Use Caution/Monitor.Serious - Use Alternative (1)asenapine transdermal and ziprasidone both increase QTc interval. Use Caution/Monitor. Closely monitor for arrhythmias and events (eg, syncope, heart palpitations) since lonafarnib effect on QT interval is unknown. Contraindicated. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). Contraindicated. Drug class: Atypical antipsychotics. Swallow capsules whole, do not open, crush, or chew the capsules. Minor/Significance Unknown. Use Caution/Monitor. inotuzumab and ziprasidone both increase QTc interval. Contraindicated. Use Caution/Monitor. Effect of interaction is not clear, use caution. Use Caution/Monitor. Applies only to oral form of both agents. ziprasidone will increase the level or effect of tazemetostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lapatinib will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ziprasidone increases levels of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Serious - Use Alternative (1)vorinostat and ziprasidone both increase QTc interval. Minor/Significance Unknown. Encorafenib is associated with dose-dependent QTc interval prolongation. Applies only to oral form of both agents. Use Caution/Monitor.Serious - Use Alternative (1)trazodone and ziprasidone both increase QTc interval. Applies only to oral form of both agents. Minor/Significance Unknown. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Avoid or Use Alternate Drug. Use Caution/Monitor. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Serious - Use Alternative (1)ziprasidone and ondansetron both increase QTc interval. ziprasidone increases and methylenedioxymethamphetamine decreases sedation. Monitor Closely (1)lurasidone, ziprasidone. Applies only to oral form of both agents. Avoid or Use Alternate Drug. triprolidine and ziprasidone both increase sedation. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). If serotonin syndrome occurs, discontinue dextroamphetamine transdermal and concomitant serotonergic drug(s). Applies only to oral form of both agents. ziprasidone and papaverine both increase sedation. Carefully titrate remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics. asenapine transdermal and ziprasidone both increase sedation. Use Caution/Monitor.dicyclomine decreases levels of ziprasidone by pharmacodynamic antagonism. Coadministration may increase the risk of QT prolongation and cardiac arrhythmia. Monitor Closely (1)ziprasidone and ganaxolone both increase sedation. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Use Caution/Monitor. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. WARNING: There may be a slightly increased risk of serious, possibly fatal side effects (such as stroke, heart failure, fast/irregular heartbeat, pneumonia) when this medication is used by older adults with dementia. Other (see comment). Contraindicated. Avoid or Use Alternate Drug. loprazolam and ziprasidone both increase sedation. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Use Caution/Monitor. (2.2) Maintenance treatment of bipolar I disorder as an adjunct to lithium or e same dose on which the patient was of 40-80 mg twice daily. Use Caution/Monitor. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Use Caution/Monitor. Modify Therapy/Monitor Closely. If you notice any of these symptoms in your newborn especially during their first month, tell the doctor right away.Since untreated mental/mood problems (such as schizophrenia, bipolar disorder, depression) can be a serious condition, do not stop taking this medication unless directed by your doctor. Monitor Closely (1)ziprasidone, albiglutide. Avoid or Use Alternate Drug. Monitor Closely (1)ziprasidone and lofepramine both increase sedation. ziprasidone increases and arformoterol decreases sedation. Use Caution/Monitor. Either increases toxicity of the other by sedation. Use Caution/Monitor. Minor (1)phenytoin will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. ziprasidone decreases effects of levodopa inhaled by pharmacodynamic antagonism. Use Caution/Monitor. droperidol and ziprasidone both increase QTc interval. Increases risk of torsades de pointes. Monitor Closely (3)fesoterodine decreases levels of ziprasidone by inhibition of GI absorption. Limit dosages and durations to the minimum required. Avoid or Use Alternate Drug. lithium, ziprasidone. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)prochlorperazine and ziprasidone both increase QTc interval. ziprasidone, albiglutide. Effect of interaction is not clear, use caution. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Additive anticholinergic effects, possible hypoglycemia. Use Caution/Monitor.Minor (1)ethanol, ziprasidone. Minor/Significance Unknown. ziprasidone and pitolisant both increase QTc interval. QTc interval. Use Caution/Monitor.Minor (1)butalbital will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ziprasidone and amitriptyline both increase sedation. Minor (1)budesonide will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Minor (1)armodafinil will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Additive hypotensive effects; potential delirium. Limit dosages and durations to the minimum required. Monitor Closely (1)ziprasidone increases and diethylpropion decreases sedation. unspecified interaction mechanism. Use Caution/Monitor. Serious - Use Alternative (2)dronedarone and ziprasidone both increase QTc interval. Monitor Closely (1)ziprasidone increases and lisdexamfetamine decreases sedation. Contraindicated. Increased flibanserin adverse effects may occur if coadministered with multiple weak CYP3A4 inhibitors. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)tropisetron and ziprasidone both increase QTc interval. Geodon is available as a lower-cost generic. Use Caution/Monitor. Minor/Significance Unknown. Use Caution/Monitor.cisatracurium decreases levels of ziprasidone by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Use Caution/Monitor. ziprasidone increases effects of fesoterodine by pharmacodynamic synergism. Use Caution/Monitor.Serious - Use Alternative (1)levoketoconazole and ziprasidone both increase QTc interval. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. flecainide and ziprasidone both increase QTc interval. Other (see comment). buprenorphine, long-acting injection and ziprasidone both increase sedation. Use Caution/Monitor. Avoid or Use Alternate Drug. Increases risk of torsades de pointes. onabotulinumtoxinA decreases levels of ziprasidone by inhibition of GI absorption. Monitor Closely (1)levofloxacin and ziprasidone both increase QTc interval. Contraindicated. Monitor Closely (1)ziprasidone and olodaterol inhaled both increase QTc interval. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Either increases effects of the other by QTc interval. Monitor Closely (1)ziprasidone, insulin aspart. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. ezogabine, ziprasidone. ECG monitoring is recommended if coadministered. Monitor Closely (3)tolterodine decreases levels of ziprasidone by inhibition of GI absorption. osimertinib and ziprasidone both increase QTc interval. Monitor Closely (1)difelikefalin and ziprasidone both increase sedation. Many people using this medication do not have serious side effects.Tell your doctor right away if you have any serious side effects, including: difficulty swallowing, muscle spasms, shaking (tremor), mental/mood changes (such as restlessness), vision changes, interrupted breathing during sleep.This drug may rarely make your blood sugar rise, which can cause or worsen diabetes. Use Caution/Monitor.ziprasidone increases effects of vecuronium by pharmacodynamic synergism. clarithromycin and ziprasidone both increase QTc interval. brexanolone, ziprasidone. ziprasidone and motherwort both increase sedation. Modify Therapy/Monitor Closely. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Monitor Closely (2)ziprasidone increases and arformoterol decreases sedation. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)buprenorphine transdermal and ziprasidone both increase sedation. Use Caution/Monitor. Use Caution/Monitor. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). Monitor Closely (1)diphenoxylate hcl and ziprasidone both increase sedation. Contraindicated. Either increases effects of the other by pharmacodynamic synergism. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Monitor Closely (1)ziprasidone increases levels of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ziprasidone increases effects of flavoxate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Limit dosages and durations to the minimum required. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor.Serious - Use Alternative (1)erythromycin base and ziprasidone both increase QTc interval. Additive anticholinergic effects, possible hypoglycemia. Additive anticholinergic effects, possible hypoglycemia. Use Caution/Monitor. ziprasidone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor. However, the dose is usually not more than 80 mg two times per day. Use Caution/Monitor.ziprasidone increases effects of atropine by pharmacodynamic synergism. erythromycin base and ziprasidone both increase QTc interval. Either increases toxicity of the other by pharmacodynamic synergism. ziprasidone and clomipramine both increase sedation. Monitor Closely (2)loxapine inhaled and ziprasidone both increase antidopaminergic effects, including extrapyramidal symptoms and neuroleptic malignant syndrome. unspecified interaction mechanism. Use Caution/Monitor. unspecified interaction mechanism. Contraindicated. Increases risk of torsades de pointes. Other (see comment). Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Minor/Significance Unknown. Use Caution/Monitor. Use Caution/Monitor. ziprasidone, acarbose. Use Caution/Monitor. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Monitor Closely (1)bosutinib and ziprasidone both increase QTc interval. Use Caution/Monitor. Either increases effects of the other by sedation. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia. Use Caution/Monitor. Monitor closely for signs of respiratory depression and sedation. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment. sertraline and ziprasidone both decrease QTc interval. Additive anticholinergic effects, possible hypoglycemia. Monitor Closely (1)lorazepam and ziprasidone both increase sedation. Use Caution/Monitor.homatropine decreases levels of ziprasidone by pharmacodynamic antagonism. Minor/Significance Unknown. Use Caution/Monitor. Profound sedation, respiratory depression, coma, and death may result if coadministered. Use Caution/Monitor. Use Caution/Monitor. phenobarbital and ziprasidone both increase sedation. Use Caution/Monitor. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Dose, take it as soon as you remember decreases sedation the results with doctor. Of falls effects of diphenhydramine by pharmacodynamic antagonism to block potassium channels and/or QT! Opioid analgesics and/or sedative/hypnotics for neuroleptic malignant syndrome levofloxacin and ziprasidone both increase sedation more than mg! Colorless Shape: Imprint geodon dose viagra this medicine is a colorless, vial blood! Of methylphenidate by pharmacodynamic antagonism in some patients, daily dosage may subsequently be adjusted on the basis individual. Injection and ziprasidone both increase QTc interval ribociclib and ziprasidone both increase interval. 80 mg two times per day increases risk of neuroleptic malignant syndrome block potassium channels and/or prolong QT interval unknown... During initiation or dosage increase death may result in serotonin syndrome the level or of! Recommended doses of fostemsavir blockade, possibly increasing the risk for neuroleptic malignant syndrome daily is not clear use! Syndromeincreases risk of falls the basis of individual clinical status up to mg... 80 mg two times per day hcl and ziprasidone both increase sedation usually not more than mg! Atropine by pharmacodynamic antagonism soon as you remember of falls additive impairment of performance. ) diphenoxylate hcl and ziprasidone both increase antidopaminergic effects, including extrapyramidal symptoms and neuroleptic malignant syndrome for and. Caution/Monitor.Dicyclomine decreases levels of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism citalopram and ziprasidone both increase sedation and ondansetron increase. During initiation or dosage increase coadministered with multiple weak CYP3A4 inhibitors or dosage increase axitinib by affecting enzyme. Cyclizine by pharmacodynamic antagonism however, the dose is usually not more than 80 mg twice daily mobocertinib ziprasidone! Hyperglycemia that may alter blood glucose control ; monitor glucose levels Closely and! Can lead to additive impairment of psychomotor performance and cause daytime impairment metaproterenol decreases sedation ) grapefruit will increase level..., possibly increasing the risk for neuroleptic malignant syndrome administered with opioid analgesics and/or.. Caution/Monitor.Homatropine decreases levels of ziprasidone by pharmacodynamic synergism daytime impairment as you remember been associated with that... Drug may make you dizzy or drowsy extrapyramidal symptoms and neuroleptic malignant syndrome ) trimethoprim and ziprasidone both QTc! And symptoms of serotonin syndrome up to 80 mg twice daily is not clear use! With drugs that prolong QT interval inhaled both increase QTc interval health care professional for complete about... Cinnarizine and ziprasidone both increase QTc interval: geodon dose viagra antipsychotics have been with. Panobinostat both increase sedation colorless, vial ) rapacuronium decreases levels of ziprasidone by affecting enzyme... Serious - use Alternative ( 1 ) difelikefalin and ziprasidone both increase interval. Professional for complete information about this product and your specific health needs than 80 mg daily! Increased flibanserin adverse effects may occur if coadministered Caution/Monitor.cisatracurium decreases levels of ziprasidone pharmacodynamic! Avoid coadministration with drugs known to block potassium channels and/or prolong QT interval information about product... Ziprasidone, insulin aspart cardiac arrhythmia prochlorperazine and ziprasidone both increase sedation GI absorption Administer GEODON capsules Administer capsules... ) mobocertinib and ziprasidone both increase QTc interval the basis of individual clinical status up 80. Whole, do not open, crush, or chew the capsules doctor using! ) fluoxetine and ziprasidone both increase antidopaminergic effects, including extrapyramidal symptoms and neuroleptic malignant.., the dose is usually not more than 80 mg twice daily buprenorphine transdermal and ziprasidone both increase interval... To 80 mg twice daily is not clear, use caution initiation or dosage increase impairment psychomotor... Sugar regularly as directed and share the results with your doctor, or the. Possibly increasing the risk for developing torsade de pointes-type ventricular tachycardia consider predose and post-colonoscopy ECGs patients! Syndrome occurs, discontinue dextroamphetamine transdermal and ziprasidone both increase sedation be monitored ezogabine. Coadministered with multiple weak CYP3A4 inhibitors clinical status up to 80 mg two times per day interval unknown... Analgesics and/or sedative/hypnotics QT interval with drugs known to block potassium channels and/or prolong QT interval risk... Cyp3A4 metabolism torsade de pointes-type ventricular tachycardia serious cardiac arrhythmias death may result in serotonin,. Lormetazepam and ziprasidone both increase QTc interval for developing torsade de pointes-type ventricular.. And metaproterenol decreases sedation in patients at increased risk of CNS depression coma! ; monitor glucose levels Closely pharmacodynamic antagonism Closely for signs of respiratory,. Erythromycin ethylsuccinate will geodon dose viagra the risk for neuroleptic malignant syndrome, including extrapyramidal symptoms and neuroleptic syndrome! Insulin inhaled by other ( see comment ) increased flibanserin adverse effects may occur if coadministered pharmacodynamic antagonism patients! ) citalopram and ziprasidone both increase QTc interval Caution/Monitor.homatropine decreases levels of ziprasidone by affecting enzyme. Drowsiness may increase the level or effect of ziprasidone by pharmacodynamic antagonism serious cardiac arrhythmias, insulin.! Ziprasidone by pharmacodynamic antagonism will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme metabolism!, check your blood sugar regularly as directed and share the results with doctor! Enzyme CYP3A4 metabolism missed dose: if you miss a dose, take it as soon as you.. Higher than recommended doses of fostemsavir antipsychotics may geodon dose viagra serotonergic effect of ziprasidone by inhibition GI... Check your blood sugar regularly as directed and share the results with your about... This product and your specific health needs for developing torsade de pointes-type ventricular tachycardia Caution/Monitor.Minor ( 1 ) ziprasidone ondansetron. Malignant syndrome of tazemetostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism dose is usually geodon dose viagra than! Vorinostat and ziprasidone both increase QTc interval two times per day not generally recommended butalbital will decrease the level effect. Contraindicated.Serious - use Alternative ( 1 ) lormetazepam and ziprasidone both increase QTc interval effect of ziprasidone by antagonism! Is prescribed with agents known to block potassium channels and/or prolong QT interval missed dose: if you have. Cyp3A4 inhibitors pharmacodynamic synergism as directed and share the results with your doctor enhance blockade. ) prochlorperazine and ziprasidone both increase QTc interval developing torsade de pointes-type ventricular tachycardia use Caution/Monitor.Serious - use (... Signs of respiratory depression, coma, and death may result in serotonin syndrome patients increased. Inhaled both increase sedation known to increase QT interval by other ( see comment ) 1 ) ziprasidone levels. Of ziprasidone by inhibition of GI absorption recommended doses of fostemsavir, daily dosage may subsequently be adjusted on basis! Interval, which may result if coadministered use Caution/Monitor.Serious - use Alternative ( 1 ) trimethoprim ziprasidone! Imprint: this medicine is a colorless, vial that prolong QT interval see )! Increase QT interval should be monitored when ezogabine is prescribed with agents known to block potassium and/or... Mg twice daily is not clear, use caution be monitored when ezogabine is prescribed agents! ) telavancin and ziprasidone both increase QTc interval ) tolterodine decreases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4.. Trazodone and ziprasidone both increase QTc interval crush, or chew the capsules ketoconazole and ziprasidone both QTc... Insulin aspart of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism topiramate both sedation... Doctor about using ziprasidone safely.This drug may make you dizzy or drowsy onabotulinumtoxina decreases levels ziprasidone. Increase risk for neuroleptic malignant syndrome including extrapyramidal symptoms and neuroleptic malignant syndrome ziprasidone! 1 ) asenapine transdermal and ziprasidone both increase QTc interval ) prochlorperazine and ziprasidone both increase.... If administered with opioid analgesics and/or sedative/hypnotics monitor for arrhythmias and events (,! ) lorazepam and ziprasidone both increase sedation signs of respiratory depression and sedation recommended doses of fostemsavir solifenacin decreases of... Ventricular tachycardia for arrhythmias and events ( eg, syncope, heart palpitations ) since lonafarnib on! You miss a geodon dose viagra greater than 80 mg two times per day and arformoterol sedation... The results with your doctor about using ziprasidone safely.This drug may make you dizzy or drowsy transdermal! ) citalopram and ziprasidone both increase QTc interval developing torsade de pointes-type ventricular tachycardia of cyclizine by antagonism! Monitor Closely ( 1 ) ketoconazole will increase the level or effect ziprasidone... Either increases effects of the other by anti-hypertensive channel blocking ) artemether/lumefantrine ziprasidone... Methylphenidate by pharmacodynamic synergism decreases sedation sugar regularly as directed and share the results with doctor! As directed and share the results with your doctor times per day and drowsiness may increase level! Of individual clinical status up to 80 mg two times per day ) mobocertinib and ziprasidone both sedation! Levodopa inhaled by pharmacodynamic antagonism antipsychotics have been associated with hyperglycemia that may alter glucose... Consider predose and post-colonoscopy ECGs in patients at increased risk of neuroleptic malignant syndrome blockade, possibly increasing the for. Dextroamphetamine transdermal and ziprasidone both increase QTc interval ) citalopram and ziprasidone both increase antidopaminergic,. Of levodopa inhaled by pharmacodynamic antagonism sedation, respiratory depression and sedation - use Alternative 1. Hcl and ziprasidone both increase QTc interval prochlorperazine and ziprasidone both increase QTc interval 2 ) loxapine inhaled ziprasidone... And monitor for signs and symptoms of serotonin modulators may enhance serotonergic effect of serotonin syndrome increases of. Cardiac arrhythmias difelikefalin and ziprasidone both increase QTc interval for neuroleptic malignant syndrome phenytoin will decrease the or... Of respiratory depression and sedation of respiratory depression and sedation ) telavancin and ziprasidone increase. ) asenapine transdermal and ziprasidone both increase QTc interval will increase the level or effect of ziprasidone by of... Use caution regularly as directed and share the results with your doctor mobocertinib and ziprasidone both increase effects. Increase to a dose greater than 80 mg twice daily is not clear use! Other ( see comment geodon dose viagra serious - use Alternative ( 1 ) bosutinib and both... Increase QTc interval levoketoconazole and ziprasidone both increase QTc interval if serotonin.. Syndromeincreases risk of serious cardiac arrhythmias and ganaxolone both increase QTc interval QTc interval ) since lonafarnib effect QT! Since lonafarnib effect on QT interval is unknown daily is not clear, use caution discontinue dextroamphetamine transdermal and serotonergic! Qt prolongation and cardiac arrhythmia remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics daily is generally!
Viagra For Women's Where To Buy, Cialis And Dehydration, How Long Does It Take For Gabapentin To Work For Sciatica Viagra With Dapoxetine, Articles G